LIGAND PHARMA (LGDN.SG)

STU:LGDN Germany Other

Market Cap

$1.85 Million

€1.80 Million EUR

Market Cap Rank

#34527 Global

#3978 in Germany

Share Price

€189.00

Change (1 day)

+0.53%

52-Week Range

€85.00 - €189.00

All Time High

€237.97

LIGAND PHARMA (LGDN.SG) - Asset Resilience Ratio

Latest as of September 2024: 16.34%

LIGAND PHARMA (LGDN.SG) (LGDN) has an Asset Resilience Ratio of 16.34% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€156.02 Million

Cash + Short-term Investments

Total Assets

€954.87 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how LIGAND PHARMA (LGDN.SG)'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down LIGAND PHARMA (LGDN.SG)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€156.02 Million	16.34%
Total Liquid Assets	€156.02 Million	16.34%

Asset Resilience Insights

Good Liquidity Position: LIGAND PHARMA (LGDN.SG) maintains a healthy 16.34% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.